Takeda has announced the appointment of Julie Kim as successor to Christophe Weber, its current president, CEO and representative director, effective from June 2026.
The decision was unanimously reached by Takeda’s board of directors.
Go deeper with GlobalData
Kim, the current president of the company’s US Business Unit, will be proposed as a candidate for election to the board at the Annual General Shareholders’ Meeting to be held in June 2026.
Following his retirement, Weber will not maintain a board seat at the company.
Kim has been with the company since 2019 as a member of the executive team and took charge of the business unit in 2022.
Her healthcare career spans three decades, with senior roles across general management, marketing and international market access.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataHer experience extends to working with therapeutic areas.
Kim said: “I am excited to guide Takeda through the next phase, together with our exceptional and talented people, while staying true to our strong culture that is rooted in our values and shaped by a heritage of more than 240 years.
“I want to thank the board of directors for their confidence in me. I look forward to working with the board, Takeda’s executive team and all colleagues to serve and create long-term value for patients, shareholders and society.”
Christophe Weber joined as chief operating officer of Takeda in April 2014.
He rose to become president and representative director in June 2014, and CEO in April 2015.
His tenure at the company has been marked by a strategic emphasis on globalisation, research and development, and the cultivation of a diverse and inclusive workplace.
In a significant move towards sustainability, Takeda announced a partnership with Boston Medical Center, in October 2024. This collaboration is focused on advancing decarbonisation initiatives within the US healthcare sector.
